Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation

@article{Schlienger2003EffectOS,
  title={Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation},
  author={R. Schlienger and C. R. Meier},
  journal={American Journal of Cardiovascular Drugs},
  year={2003},
  volume={3},
  pages={149-162}
}
  • R. Schlienger, C. R. Meier
  • Published 2003
  • Medicine
  • American Journal of Cardiovascular Drugs
  • In recent years a large body of evidence from several longitudinal studies has emerged suggesting that depression is an independent risk factor for cardiovascular disease (CVD) and that the association between depression and increased CVD risk is not merely due to negative mood-driven behavior related with depression. Even though the underlying mechanisms are not well understood, several hypotheses and explanations have been proposed such as increased activation of the hypothalamic-pituitary… CONTINUE READING
    41 Citations
    Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
    • 61
    • PDF
    The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders
    • 18
    Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability
    • 33
    Venous thromboembolism and escitalopram.
    • 28
    5‐HYDROXYTRYPTAMINE IN THE CARDIOVASCULAR SYSTEM: FOCUS ON THE SEROTONIN TRANSPORTER (SERT)
    • W. Ni, S. Watts
    • Medicine, Biology
    • Clinical and experimental pharmacology & physiology
    • 2006
    • 148
    Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression
    • 53

    References

    SHOWING 1-10 OF 115 REFERENCES
    Abnormal Platelet Aggregation Associated with Fluoxetine Therapy
    • 65
    Role of catecholamines in platelet function: pathophysiological and clinical significance
    • 159
    Platelets and coronary heart disease: potential psychophysiologic mechanisms.
    • 175
    Exaggerated platelet reactivity in major depression.
    • 522
    Clinical overview of serotonin reuptake inhibitors.
    • 163